Successful treatment of recalcitrant pyoderma gangrenosum with infliximab complicated by tuberculosis despite negative screening tests
- 30 March 2005
- journal article
- Published by Wiley in Clinical and Experimental Dermatology
- Vol. 30 (3) , 294
- https://doi.org/10.1111/j.1365-2230.2004.01716.x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Miliary tuberculosis after infliximab therapy in LebanonClinical Rheumatology, 2004
- Infliximab as a treatment for recalcitrant pyoderma gangrenosumClinical and Experimental Dermatology, 2004
- Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody).British Journal of Dermatology, 2004
- Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel diseaseAmerican Journal of Gastroenterology, 2003
- Corticosteroid-Resistant Pyoderma gangrenosum Associated with Crohn’s Disease: Rapid Cure with InfliximabDermatology, 2002